Table 3: Biodistribution of 18F-FDG in mesothelioma-bearing rats.

Percentage of injected dose per gram of tissue weight ( 𝑛 = 3 /time, interval, iv)1
30 min90 min180 min

Blood 0 . 4 5 ± 0 . 0 7 0 . 1 5 ± 0 . 0 1 0 . 0 7 ± 0 . 0 1
Heart 3 . 4 2 ± 1 . 1 4 1 . 9 5 ± 0 . 4 0 1 . 9 4 ± 0 . 4 5
Lung 0 . 6 0 ± 0 . 0 7 0 . 5 3 ± 0 . 0 3 0 . 4 6 ± 0 . 0 6
Thyroid 0 . 6 5 ± 0 . 0 4 0 . 4 7 ± 0 . 0 5 0 . 5 4 ± 0 . 0 4
Pancreas 0 . 2 2 ± 0 . 0 2 0 . 2 1 ± 0 . 0 2 0 . 2 1 ± 0 . 0 3
Liver 0 . 5 1 ± 0 . 0 8 0 . 3 3 ± 0 . 0 3 0 . 2 3 ± 0 . 0 3
Spleen 0 . 8 8 ± 0 . 0 8 0 . 8 7 ± 0 . 0 6 0 . 9 8 ± 0 . 1 0
Kidney 0 . 8 5 ± 0 . 1 3 0 . 4 3 ± 0 . 0 4 0 . 2 3 ± 0 . 0 1
Stomach 0 . 5 5 ± 0 . 0 3 0 . 4 0 ± 0 . 0 3 0 . 3 8 ± 0 . 0 2
Intestine 0 . 9 4 ± 0 . 1 6 1 . 0 0 ± 0 . 2 2 0 . 6 2 ± 0 . 0 7
Uterus 0 . 5 2 ± 0 . 0 6 0 . 5 7 ± 0 . 0 8 0 . 3 9 ± 0 . 0 9
Tumor 1 . 8 6 ± 0 . 2 2 1 . 6 3 ± 0 . 1 9 1 . 3 8 ± 0 . 3 5
Muscle 0 . 4 5 ± 0 . 1 4 0 . 2 3 ± 0 . 0 3 0 . 4 2 ± 0 . 0 6
Bone 0 . 2 1 ± 0 . 0 9 0 . 1 4 ± 0 . 0 7 0 . 2 4 ± 0 . 0 6
Brain 2 . 3 6 ± 0 . 1 0 2 . 2 4 ± 0 . 2 0 1 . 8 9 ± 0 . 3 5
Tumor/blood 4 . 1 9 ± 0 . 4 4 1 1 . 0 1 ± 1 . 6 0 1 9 . 4 1 ± 2 . 0 5
Tumor/muscle 5 . 7 5 ± 2 . 5 5 7 . 4 0 ± 1 . 6 7 3 . 3 3 ± 0 . 6 5
Tumor/brain 0 . 7 7 ± 0 . 0 9 0 . 7 2 ± 0 . 0 2 0 . 7 1 ± 0 . 0 5
Uterus/muscle 1 . 5 8 ± 0 . 6 9 2 . 5 0 ± 0 . 3 7 0 . 9 4 ± 0 . 1 6
Tumor/lung 3 . 1 8 ± 0 . 4 4 3 . 4 1 ± 0 . 4 3 2 . 9 2 ± 0 . 3 4

1Values shown represent the mean ± standard deviation of data from 3 animals.